Supernus, Inc. (SUPN) stock
SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$29.04+0.21 (+0.73%)
Close on Nov 17, 2026Market cap $3.43BP/E 8.1Yield –
Supernus operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Supernus's operating cash flow for the twelve months ending Sep 30, 2026 was $96.00M, down 45.8% year over year. For fiscal 2025 it was -$27.00M, down 175.0% from the year before. The highest annual figure on record is $353.00M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$27.00M | -175.0% |
| FY2024 | Dec 31, 2024 | $36.00M | – |
| FY2023 | Dec 31, 2023 | -$300.00M | – |
| FY2022 | Dec 31, 2022 | -$4.00M | -101.1% |
| FY2021 | Dec 31, 2021 | $353.00M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $97.00M | – |
| Q2 FY2026 | Jun 30, 2026 | $229.00M | +44.9% |
| Q1 FY2026 | Mar 31, 2026 | -$9.00M | -112.0% |
| Q4 FY2025 | Dec 31, 2025 | -$221.00M | – |
| Q3 FY2025 | Sep 30, 2025 | -$39.00M | -2050.0% |
| Q2 FY2025 | Jun 30, 2025 | $158.00M | +79.5% |
| Q1 FY2025 | Mar 31, 2025 | $75.00M | – |
| Q4 FY2024 | Dec 31, 2024 | -$17.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $2.00M | – |
| Q2 FY2024 | Jun 30, 2024 | $88.00M | – |
| Q1 FY2024 | Mar 31, 2024 | -$37.00M | – |
See a number that looks wrong?